SCHEMBL28787151

SCHEMBL28787151

COc1cc(=O)c2ccc(OC)c(OC)c2o1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.60
CYP2C19 P33261 2/20 0.60
CYP1A2 P05177 2/20 0.60
NCOA1 Q15788 1/20 0.60
NCOA3 Q9Y6Q9 1/20 0.60
ALDH1A1 P00352 3/20 0.58
KDM4E B2RXH2 2/20 0.58
TERT O14746 8/20 0.58
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA7 P43166 1/20 0.54
CA9 Q16790 1/20 0.54
CA13 Q8N1Q1 1/20 0.54
MAOA P21397 1/20 0.52
CYP1A1 P04798 3/20 0.45
CYP1B1 Q16678 2/20 0.45
POLB P06746 1/20 0.45
GAA P10253 1/20 0.45
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9976086 0.84 ALDH1A1 (0.62) CYP3A4CYP2C19CYP1A2NCOA1NCOA3
SCHEMBL4649487 0.78 CYP3A4 (0.76) CYP3A4CYP2C19CYP1A2NCOA1NCOA3
SCHEMBL29612043 0.78 TERT (0.77) CYP3A4CYP2C19CYP1A2NCOA1NCOA3
SCHEMBL5617428 0.78 ODC1 (0.65) CYP3A4CYP2C19CYP1A2NCOA1NCOA3
SCHEMBL988001 0.78 TERT (0.77) CYP3A4CYP2C19CYP1A2NCOA1NCOA3
SCHEMBL6801603 0.77 CYP3A4 (0.65) CYP3A4CYP2C19CYP1A2NCOA1NCOA3
SCHEMBL6616218 0.77 CYP3A4 (0.73) CYP3A4CYP2C19CYP1A2NCOA1NCOA3
SCHEMBL6612282 0.77 TUBB4A (0.76) CYP3A4CYP2C19CYP1A2NCOA1NCOA3
SCHEMBL21647169 0.76 CYP1A2 (0.73) CYP3A4CYP2C19CYP1A2NCOA1NCOA3
SCHEMBL14286203 0.76 CYP1A2 (1.00) CYP3A4CYP2C19CYP1A2NCOA1NCOA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110498784-B Nobiletin derivatives or pharmaceutically acceptable salts thereof, and preparation method and application thereof 广东克冠达医药科技有限公司 2022-06-14 CN disclosed